Brokerages Anticipate Prestige Consumer Healthcare Inc. (NYSE:PBH) Will Post Earnings of $1.10 Per Share

Wall Street analysts expect that Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) will announce earnings per share (EPS) of $1.10 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with the lowest EPS estimate coming in at $1.06 and the highest estimate coming in at $1.14. Prestige Consumer Healthcare posted earnings per share of $1.14 during the same quarter last year, which would indicate a negative year-over-year growth rate of 3.5%. The business is scheduled to report its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Prestige Consumer Healthcare will report full-year earnings of $4.27 per share for the current year, with EPS estimates ranging from $4.21 to $4.32. For the next financial year, analysts forecast that the company will post earnings of $4.47 per share, with EPS estimates ranging from $4.43 to $4.50. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that follow Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBH – Get Rating) last announced its earnings results on Thursday, May 5th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $266.94 million during the quarter, compared to analysts’ expectations of $258.25 million. Prestige Consumer Healthcare had a net margin of 18.90% and a return on equity of 14.08%. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the company posted $0.79 EPS.

Several equities research analysts have weighed in on PBH shares. Oppenheimer upgraded shares of Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 price objective for the company in a research report on Monday. StockNews.com started coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, March 31st. They issued a “buy” rating for the company. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Hold” and an average target price of $78.00.

Large investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $26,000. Rockefeller Capital Management L.P. grew its position in shares of Prestige Consumer Healthcare by 54.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 843 shares of the company’s stock worth $51,000 after buying an additional 297 shares during the period. Point72 Hong Kong Ltd grew its position in shares of Prestige Consumer Healthcare by 1,705.4% during the 4th quarter. Point72 Hong Kong Ltd now owns 1,679 shares of the company’s stock worth $102,000 after buying an additional 1,586 shares during the period. Okabena Investment Services Inc. acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $114,000. Finally, Islay Capital Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $129,000.

Shares of Prestige Consumer Healthcare stock traded up $2.88 during mid-day trading on Monday, reaching $57.76. 7,899 shares of the stock were exchanged, compared to its average volume of 271,543. The company has a market capitalization of $2.90 billion, a P/E ratio of 14.25, a price-to-earnings-growth ratio of 1.60 and a beta of 0.58. The company has a current ratio of 2.04, a quick ratio of 1.25 and a debt-to-equity ratio of 1.01. The company has a 50-day simple moving average of $54.79. Prestige Consumer Healthcare has a fifty-two week low of $45.93 and a fifty-two week high of $63.83.

Prestige Consumer Healthcare Company Profile (Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Read More